Michael Weller

Royal College of Surgeons in Ireland — Ireland

Medicine · Health Sciences

174h-index162.4kcitations2.8kworks7.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(1192), Brain Metastases and Treatment(423), Radiomics and Machine Learning in Medical Imaging(190), Meningioma and schwannoma management(148), Cancer, Hypoxia, and Metabolism(125)

Publications2.7k total

Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosis
Multiple Sclerosis and Related Disorders·2025Open Access
Ein innovativer Ansatz – longitudinales Monitoring mittels Liquorproben
InFo Hämatologie + Onkologie·2025
Mehr makroskopische Komplettresektionen durch intraoperative MRI?
InFo Neurologie + Psychiatrie·2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
The Lancet Oncology·2025· 4 citedOpen Access
Table S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Figure S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Figure S3 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Supplementary Figure S4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
2025Open Access
Supplementary Figure S1 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
2025Open Access
Figure S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Table S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Supplementary Figure S3 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
2025Open Access
Figure S7 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Figure S5 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Figure S6 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Figure S8 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Figure S1 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Supplementary Tables 1, 3, 5-7 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
2025Open Access
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma
JAMA Network Open·2025· 1 citedOpen Access
Supplementary Tables S1-4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
2025Open Access
page 1 of 138Next →

Frequent Co-authors

Wolfgang Wick(25), Guido Reifenberger(18), Martin J. van den Bent(17), Roger Stupp(16), Andreas von Deimling(16), Monika E. Hegi(13), Matthias Preusser(11), Alba A. Brandes(9), Michael Platten(8), Émilie Le Rhun(8), Felix Sahm(7), Riccardo Soffietti(7), Torsten Pietsch(7), Martin Taphoorn(6), Thierry Gorlia(6), Matthias Simon(6), Pieter Wesseling(5), Giuseppe Minniti(5), Manfred Westphal(5), David A. Reardon(5)